The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by a Single Amino Acid Difference and Suggests a Mechanism of Action for These Inhibitors

Journal of Virology - Tập 78 Số 8 - Trang 4134-4144 - 2004
Erika Billick1, Christoph Seibert2, Pavel Pugach3, Tom Ketas3, Alexandra Trkola4, M. Endres5, Nicholas Murgolo5, Elizabeth Coates5, Gregory R. Reyes5, Bahige M. Baroudy5, Thomas P. Sakmar2, John P. Moore3, Shawn E. Kuhmann3
1Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York 10021, USA.
2Laboratory of Molecular Biology and Biochemistry, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10021
3Department of Microbiology and Immunology, Weill Medical College of Cornell University,
4Division of Infectious Diseases, Department of Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.
5 Schering Plough Research Institute, Kenilworth, New Jersey 07033

Tóm tắt

ABSTRACTAD101 and SCH-C are two chemically related small molecules that inhibit the entry of human immunodeficiency virus type 1 (HIV-1) via human CCR5. AD101 also inhibits HIV-1 entry via rhesus macaque CCR5, but SCH-C does not. Among the eight residues that differ between the human and macaque versions of the coreceptor, only one, methionine-198, accounts for the insensitivity of macaque CCR5 to inhibition by SCH-C. Thus, the macaque coreceptor engineered to contain the natural human CCR5 residue (isoleucine) at position 198 is sensitive to HIV-1 entry inhibition by SCH-C, whereas a human CCR5 mutant containing the corresponding macaque residue (methionine) is resistant. Position 198 is in CCR5 transmembrane (TM) helix 5 and is not located within the previously defined binding site for AD101 and SCH-C, which involves residues in TM helices 1, 2, 3, and 7. SCH-C binds to human CCR5 whether residue 198 is isoleucine or methionine, and it also binds to macaque CCR5. However, the binding of a conformation-dependent monoclonal antibody to human CCR5 is inhibited by SCH-C only when residue 198 is isoleucine. These observations, taken together, suggest that the antiviral effects of SCH-C and AD101 involve stabilization, or induction, of a CCR5 conformation that is not compatible with HIV-1 infection. However, SCH-C is unable to exert this effect on CCR5 conformation when residue 198 is methionine. The region of CCR5 near residue 198 has, therefore, an important influence on the conformational state of this receptor.

Từ khóa


Tài liệu tham khảo

10.1038/ng0797-221

10.1073/pnas.96.10.5698

10.1074/jbc.M205684200

10.1182/blood.V96.5.1638

10.1093/hmg/8.10.1939

10.1086/301645

10.1021/bi026639s

10.1128/jvi.71.4.2705-2714.1997

10.1128/jvi.64.1.215-221.1990

10.1099/0022-1317-83-8-1809

10.1073/pnas.240469997

10.1006/viro.1995.1016

10.1128/JVI.76.17.8953-8957.2002

10.1128/JVI.75.12.5541-5549.2001

10.1146/annurev.genom.3.022502.103149

10.1126/science.273.5283.1856

10.1006/viro.2000.0612

10.1099/0022-1317-82-8-1807

10.1128/jvi.67.4.2355-2359.1993

10.1128/JVI.72.1.279-285.1998

10.1073/pnas.090576697

10.1073/pnas.96.21.12004

10.1073/pnas.091056898

10.1128/JVI.75.4.1990-1995.2001

10.1126/science.284.5415.816

10.1074/jbc.274.23.16228

10.1016/S0968-0896(03)00161-5

10.1056/NEJMra022812

Koopmann, W., C. Ediriwickrema, and M. S. Krangel. 1999. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1β. J. Immunol.163:2120-2127.

10.1074/jbc.272.15.10103

10.1128/jvi.71.11.8642-8656.1997

10.1021/bi002593w

10.1074/jbc.274.14.9617

10.1016/S0092-8674(00)80110-5

10.1021/bi002670n

10.1126/science.282.5395.1907

10.1016/S0960-894X(02)00918-6

10.1016/S0140-6736(98)04158-0

Meanwell, N. A., and J. F. Kadow. 2003. Inhibitors of the entry of HIV into host cells. Curr. Opin. Drug Discov. Dev.6:451-461.

10.1074/jbc.271.32.19084

10.1126/science.276.5309.51

10.1073/pnas.1932511100

10.1038/35036060

10.1038/nm0798-786

10.1038/89653

10.1034/j.1600-065X.2000.17710.x

10.1128/JVI.73.5.4145-4155.1999

10.1021/jm015526o

10.1021/jm0200815

10.1126/science.289.5480.739

10.1016/S0006-3495(02)75307-1

10.1086/320701

10.1038/nrm908

10.2174/1568005024605864

10.1074/jbc.M010867200

10.1016/S0140-6736(97)09185-X

10.1128/JVI.72.4.3464-3468.1998

10.1073/pnas.252469399

10.1038/35073673

10.1089/088922200308747

10.1038/382722a0

10.1038/nrd795

Seibert C. W. Ying S. Gavrilov F. Tsamis S. E. Kuhmann A. Palani J. R. Tagat J. W. Clader S. W. McCombie B. M. Baroudy S. O. Smith T. Dragic J. P. Moore and T. P. Sakmar. Interaction of small molecule inhibitors of HIV-1 entry with CCR5. J. Biol. Chem. in press.

10.1016/S0969-2126(03)00011-X

10.1073/pnas.91.4.1214

10.1073/pnas.221375398

10.1016/S0960-894X(01)00381-X

10.1021/jm0155401

10.1073/pnas.012519099

10.1128/JVI.77.9.5201-5208.2003

10.1084/jem.186.8.1373

10.1084/jem.185.9.1681

10.1128/JVI.74.15.6893-6910.2000

Thông tin
Thông tin xuất bản

Journal of Virology

Tập 78 Số 8

4134-4144

Thông tin tác giả